瘤胃球菌
肠道菌群
肝硬化
真细菌
拟杆菌
丙氨酸转氨酶
普雷沃菌属
肝细胞癌
天冬氨酸转氨酶
生物
肝病
内科学
胃肠病学
医学
免疫学
酶
碱性磷酸酶
细菌
生物化学
遗传学
作者
Zhifang Zhao,Qingwei Song,Li Wang,Lili Li,Youde Liu,Lixia Deng,Zhiqiang Zou
出处
期刊:Chinese Journal of Biotechnology
[Elsevier BV]
日期:2021-01-25
卷期号:37 (1): 301-311
标识
DOI:10.13345/j.cjb.200279
摘要
Chronic hepatitis B (CHB) is a global epidemic disease caused by hepatitis B virus that can lead to hepatic failure, even liver cirrhosis and hepatocellular carcinoma. The occurrence and development of CHB are closely related to the changes in the gut microbiota communities. To explore the relationship between the structure of gut microbiota and liver biochemical indicators, 14 CHB patients (the CHB group) and 11 healthy people (the CN group) were randomly enrolled in this study. Our results demonstrate that CHB caused changes in the gut microbiota communities and biochemical indicators, such as alanine transaminase, total bilirubin and gamma glutamyl transferase. Furthermore, CHB induced imbalance of the gut microbiota. Prevotella, Blautia, Ruminococcus, Eubacterium eligens group, Bacteroides uniformis and Ruminococcus sp. 5_1_39BFAA were associated with the critical biochemical indicators and liver injury, suggesting a new approach to CHB treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI